Amicogen Inc - Asset Resilience Ratio

Latest as of December 2025: 0.43%

Amicogen Inc (092040) has an Asset Resilience Ratio of 0.43% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Amicogen Inc carry for a breakdown of total debt and financial obligations.

Liquid Assets

₩1.00 Billion
≈ $679.59K USD Cash + Short-term Investments

Total Assets

₩231.86 Billion
≈ $157.13 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Amicogen Inc's Asset Resilience Ratio has changed over time. See Amicogen Inc net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Amicogen Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Amicogen Inc (092040) market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩1.00 Billion 0.43%
Total Liquid Assets ₩1.00 Billion 0.43%

Asset Resilience Insights

  • Limited Liquidity: Amicogen Inc maintains only 0.43% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Amicogen Inc Industry Peers by Asset Resilience Ratio

Compare Amicogen Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 9.09%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.02%
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
Drug Manufacturers - Specialty & Generic 0.01%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%

Annual Asset Resilience Ratio for Amicogen Inc (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Amicogen Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.43% ₩1.00 Billion
≈ $679.59K
₩231.86 Billion
≈ $157.13 Million
-2.64pp
2024-12-31 3.07% ₩9.03 Billion
≈ $6.12 Million
₩294.23 Billion
≈ $199.39 Million
-5.18pp
2023-12-31 8.25% ₩38.54 Billion
≈ $26.12 Million
₩467.10 Billion
≈ $316.55 Million
+2.74pp
2022-12-31 5.51% ₩23.68 Billion
≈ $16.05 Million
₩429.65 Billion
≈ $291.17 Million
-4.83pp
2021-12-31 10.34% ₩42.52 Billion
≈ $28.81 Million
₩411.22 Billion
≈ $278.68 Million
-5.19pp
2020-12-31 15.53% ₩43.99 Billion
≈ $29.81 Million
₩283.37 Billion
≈ $192.03 Million
+4.56pp
2019-12-31 10.97% ₩26.47 Billion
≈ $17.94 Million
₩241.40 Billion
≈ $163.59 Million
+4.57pp
2018-12-31 6.40% ₩14.79 Billion
≈ $10.02 Million
₩231.21 Billion
≈ $156.69 Million
-7.19pp
2017-12-31 13.58% ₩22.21 Billion
≈ $15.05 Million
₩163.51 Billion
≈ $110.81 Million
+3.86pp
2016-12-31 9.73% ₩14.23 Billion
≈ $9.65 Million
₩146.33 Billion
≈ $99.17 Million
+3.00pp
2015-12-31 6.73% ₩10.76 Billion
≈ $7.29 Million
₩159.84 Billion
≈ $108.32 Million
-2.67pp
2014-12-31 9.40% ₩5.11 Billion
≈ $3.46 Million
₩54.37 Billion
≈ $36.84 Million
--
pp = percentage points

About Amicogen Inc

KQ:092040 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$67.86 Million
₩100.14 Billion KRW
Market Cap Rank
#20691 Global
#1246 in Korea
Share Price
₩1812.00
Change (1 day)
-3.87%
52-Week Range
₩1175.00 - ₩4690.00
All Time High
₩22094.22
About

Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company develops, produces, and sells of enzymes and new materials; and produces food-related additives and health functional food. It manufactures and sells of biopharmaceutical materials and resins for purifying pharmaceutical proteins and health and beauty products. In addition, the company o… Read more